Humacyte, Inc. (HUMA)
0.9745
+0.01
(+1.46%)
USD |
NASDAQ |
Jan 02, 16:00
0.9701
0.00 (0.00%)
After-Hours: 19:46
Humacyte Research and Development Expense (TTM): 75.35M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| CorMedix, Inc. | 12.46M |
| Rockwell Medical, Inc. | 0.001M |
| Nuwellis, Inc. | 2.659M |
| Salarius Pharmaceuticals, Inc. | 0.4291M |
| Biomea Fusion, Inc. | 79.10M |